PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response von Riad, Aladdin, Gitto, Sarah B, Lee, Hwan, Winters, Harrison D, Martorano, Paul M, Hsieh, Chia-Ju, Xu, Kuiying, Omran, Dalia K, Powell, Jr, Daniel J, Mach, Robert H, Makvandi, Mehran

Volltext

PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response von Riad, Aladdin, Gitto, Sarah B., Lee, Hwan, Winters, Harrison D., Martorano, Paul M., Hsieh, Chia-Ju, Xu, Kuiying, Omran, Dalia K., Powell, Daniel J., Mach, Robert H., Makvandi, Mehran

Volltext

Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma von Batra, Vandana, Samanta, Minu, Makvandi, Mehran, Groff, David, Martorano, Paul, Elias, Jimmy, Ranieri, Pietro, Tsang, Matthew, Hou, Catherine, Li, Yimei, Pawel, Bruce, Martinez, Daniel, Vaidyanathan, Ganesan, Carlin, Sean, Pryma, Daniel A, Maris, John M

Volltext

PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma von Lee, Hwan, Riad, Aladdin, Martorano, Paul, Mansfield, Adam, Samanta, Minu, Batra, Vandana, Mach, Robert H, Maris, John M, Pryma, Daniel A, Makvandi, Mehran

Volltext

Imatinib alleviates lung injury and prolongs survival in ventilated rats von Xin, Yi, Cereda, Maurizio, Yehya, Nadir, Humayun, Shiraz, Delvecchio, Paolo, Thompson, Jill M, Martin, Kevin, Hamedani, Hooman, Martorano, Paul, Duncan, Ian, Kadlecek, Stephen, Makvandi, Mehran, Brenner, Jacob S, Rizi, Rahim R

Volltext

PARP-1–Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma von Lee, Hwan, Riad, Aladdin, Martorano, Paul, Mansfield, Adam, Samanta, Minu, Batra, Vandana, Mach, Robert H., Maris, John M., Pryma, Daniel A., Makvandi, Mehran

Volltext

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma von Makvandi, Mehran, Samanta, Minu, Martorano, Paul, Lee, Hwan, Gitto, Sarah B., Patel, Khushbu, Groff, David, Pogoriler, Jennifer, Martinez, Daniel, Riad, Aladdin, Dabagian, Hannah, Zaleski, Michael, Taghvaee, Tara, Xu, Kuiying, Lee, Ji Youn, Hou, Catherine, Farrel, Alvin, Batra, Vandana, Carlin, Sean D., Powell, Daniel J., Mach, Robert H., Pryma, Daniel A., Maris, John M.

Volltext

PARP Targeted Alpha-Particle Therapy Enhances Response to PD‑1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma von Dabagian, Hannah, Taghvaee, Tahereh, Martorano, Paul, Martinez, Daniel, Samanta, Minu, Watkins, Carolyn M, Chai, Richard, Mansfield, Adam, Graham, Thomas J, Maris, John M, Pryma, Daniel A, Mach, Robert H, Makvandi, Mehran

Volltext

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma von Makvandi, Mehran, Samanta, Minu, Martorano, Paul, Lee, Hwan, Gitto, Sarah B., Patel, Khushbu, Groff, David, Pogoriler, Jennifer, Martinez, Daniel, Riad, Aladdin, Dabagian, Hannah, Zaleski, Michael, Taghvaee, Tara, Xu, Kuiying, Lee, Ji Youn, Hou, Catherine, Farrel, Alvin, Batra, Vandana, Carlin, Sean D., Powell, Daniel J., Mach, Robert H., Pryma, Daniel A., Maris, John M.

Volltext